» Articles » PMID: 16887003

Mouse Models of Breast Cancer Metastasis

Overview
Specialty Oncology
Date 2006 Aug 5
PMID 16887003
Citations 172
Authors
Affiliations
Soon will be listed here.
Abstract

Metastatic spread of cancer cells is the main cause of death of breast cancer patients, and elucidation of the molecular mechanisms underlying this process is a major focus in cancer research. The identification of appropriate therapeutic targets and proof-of-concept experimentation involves an increasing number of experimental mouse models, including spontaneous and chemically induced carcinogenesis, tumor transplantation, and transgenic and/or knockout mice. Here we give a progress report on how mouse models have contributed to our understanding of the molecular processes underlying breast cancer metastasis and on how such experimentation can open new avenues to the development of innovative cancer therapy.

Citing Articles

Experimental Induction of Mammary Carcinogenesis Using 7,12-Dimethylbenz(a)anthracene and Xenograft in Rats.

Kontogeorgi A, Boutas I, Koufopoulos N, Dimas D, Sitara K, Makrigiannakis A Cureus. 2025; 17(1):e77648.

PMID: 39968429 PMC: 11833382. DOI: 10.7759/cureus.77648.


Mammary Cancer Models: An Overview from the Past to the Future.

Silva J, Oliveira P, Duarte J, Faustino-Rocha A In Vivo. 2024; 39(1):1-16.

PMID: 39740866 PMC: 11705154. DOI: 10.21873/invivo.13800.


Elucidating Sex-Specific Immune Profiles in a Breast Cancer Model.

Hargrove-Wiley E, Obodo D, Bindeman W, Fingleton B Int J Mol Sci. 2024; 25(23).

PMID: 39684829 PMC: 11641823. DOI: 10.3390/ijms252313113.


A novel micropeptide miPEP205 suppresses the growth and metastasis of TNBC.

Zhang Z, Li F, Dai X, Deng J, Wang Y, Zhang S Oncogene. 2024; 44(8):513-529.

PMID: 39623077 DOI: 10.1038/s41388-024-03240-9.


Evaluation of Targeted Alpha Therapy Using [At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models.

Abe K, Watabe T, Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Naka S Int J Mol Sci. 2024; 25(21).

PMID: 39519118 PMC: 11547022. DOI: 10.3390/ijms252111567.


References
1.
Li Y, Hively W, Varmus H . Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene. 2000; 19(8):1002-9. DOI: 10.1038/sj.onc.1203273. View

2.
Green J, Shibata M, Yoshidome K, Liu M, Jorcyk C, Anver M . The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene. 2000; 19(8):1020-7. DOI: 10.1038/sj.onc.1203280. View

3.
Lohler J, Gocht A, Deppert W . A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland. Oncogene. 2000; 19(8):1028-37. DOI: 10.1038/sj.onc.1203281. View

4.
Kawamoto S, Niwa H, Tashiro F, Sano S, Kondoh G, Takeda J . A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett. 2000; 470(3):263-8. DOI: 10.1016/s0014-5793(00)01338-7. View

5.
Rothenberg M, Pollard J . Postnatal mammary gland development requires macrophages and eosinophils. Development. 2000; 127(11):2269-82. DOI: 10.1242/dev.127.11.2269. View